Published in Gene Therapy Weekly, October 16th, 1995
To focus resources on research and development, Chiron also announced a reduction of approximately 20 percent of the approximately 160 positions at Chiron Viagene, primarily in general and administrative functions, but including employees in other areas.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.